Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.

Michelfelder S, Fischer F, Wäldin A, Hörle KV, Pohl M, Parsons J, Reski R, Decker EL, Zipfel PF, Skerka C, Häffner K.

J Am Soc Nephrol. 2018 Apr;29(4):1141-1153. doi: 10.1681/ASN.2017070738. Epub 2018 Jan 15.

PMID:
29335241
2.

Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.

Michelfelder S, Parsons J, Bohlender LL, Hoernstein SNW, Niederkrüger H, Busch A, Krieghoff N, Koch J, Fode B, Schaaf A, Frischmuth T, Pohl M, Zipfel PF, Reski R, Decker EL, Häffner K.

J Am Soc Nephrol. 2017 May;28(5):1462-1474. doi: 10.1681/ASN.2015070745. Epub 2016 Dec 8.

3.

A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases.

Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, Kleinschmidt JA, Schwaninger M, Trepel M.

EMBO Mol Med. 2016 Jun 1;8(6):609-25. doi: 10.15252/emmm.201506078. Print 2016 Jun.

4.

Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries.

Körbelin J, Sieber T, Michelfelder S, Lunding L, Spies E, Hunger A, Alawi M, Rapti K, Indenbirken D, Müller OJ, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M.

Mol Ther. 2016 Jun;24(6):1050-1061. doi: 10.1038/mt.2016.62. Epub 2016 Mar 28.

5.

Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.

Trepel M, Körbelin J, Spies E, Heckmann MB, Hunger A, Fehse B, Katus HA, Kleinschmidt JA, Müller OJ, Michelfelder S.

Gene Ther. 2015 Oct;22(10):848. doi: 10.1038/gt.2015.76. No abstract available.

PMID:
26446851
6.

Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.

Trepel M, Körbelin J, Spies E, Heckmann MB, Hunger A, Fehse B, Katus HA, Kleinschmidt JA, Müller OJ, Michelfelder S.

Gene Ther. 2015 Oct;22(10):840-7. doi: 10.1038/gt.2015.52. Epub 2015 Jun 2. Erratum in: Gene Ther. 2015 Oct;22(10):848.

PMID:
26034897
7.

Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.

Häffner K, Michelfelder S, Pohl M.

Pediatr Nephrol. 2015 Nov;30(11):1951-9. doi: 10.1007/s00467-015-3111-9. Epub 2015 May 19.

PMID:
25986912
8.

Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions.

Naumer M, Ying Y, Michelfelder S, Reuter A, Trepel M, Müller OJ, Kleinschmidt JA.

Hum Gene Ther. 2012 May;23(5):492-507. doi: 10.1089/hum.2011.139. Epub 2012 Feb 23.

PMID:
22171602
9.

Novel cytotoxic vectors based on adeno-associated virus.

Kohlschütter J, Michelfelder S, Trepel M.

Toxins (Basel). 2010 Dec;2(12):2754-68. doi: 10.3390/toxins2122754. Epub 2010 Dec 1.

10.

Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.

Varadi K, Michelfelder S, Korff T, Hecker M, Trepel M, Katus HA, Kleinschmidt JA, Müller OJ.

Gene Ther. 2012 Aug;19(8):800-9. doi: 10.1038/gt.2011.143. Epub 2011 Sep 29.

PMID:
21956692
11.

Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.

Michelfelder S, Varadi K, Raupp C, Hunger A, Körbelin J, Pahrmann C, Schrepfer S, Müller OJ, Kleinschmidt JA, Trepel M.

PLoS One. 2011;6(8):e23101. doi: 10.1371/journal.pone.0023101. Epub 2011 Aug 5.

12.

Adeno-associated viral vectors and their redirection to cell-type specific receptors.

Michelfelder S, Trepel M.

Adv Genet. 2009;67:29-60. doi: 10.1016/S0065-2660(09)67002-4. Review.

PMID:
19914449
13.

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries.

Michelfelder S, Kohlschütter J, Skorupa A, Pfennings S, Müller O, Kleinschmidt JA, Trepel M.

PLoS One. 2009;4(4):e5122. doi: 10.1371/journal.pone.0005122. Epub 2009 Apr 9.

14.

Drug delivery in acute myeloid leukemia.

Kohlschütter J, Michelfelder S, Trepel M.

Expert Opin Drug Deliv. 2008 Jun;5(6):653-63. doi: 10.1517/17425247.5.6.653 . Review.

PMID:
18532921
15.

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.

Michelfelder S, Lee MK, deLima-Hahn E, Wilmes T, Kaul F, Müller O, Kleinschmidt JA, Trepel M.

Exp Hematol. 2007 Dec;35(12):1766-76. Epub 2007 Oct 17.

PMID:
17920758
16.

Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.

Binder M, Vögtle FN, Michelfelder S, Müller F, Illerhaus G, Sundararajan S, Mertelsmann R, Trepel M.

Cancer Res. 2007 Apr 15;67(8):3518-23.

Supplemental Content

Loading ...
Support Center